These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7739018)

  • 41. Recognition and signal transduction mechanism of Escherichia coli heat-stable enterotoxin and its receptor, guanylate cyclase C.
    Hasegawa M; Shimonishi Y
    J Pept Res; 2005 Feb; 65(2):261-71. PubMed ID: 15705168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A non-haemagglutinating form of Clostridium difficile toxin A.
    Kamiya S; Borriello SP
    J Med Microbiol; 1992 Mar; 36(3):190-7. PubMed ID: 1548692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exogenous phosphatidylcholine supplementation improves intestinal barrier defense against Clostridium difficile toxin.
    Olson A; Diebel LN; Liberati DM
    J Trauma Acute Care Surg; 2014 Oct; 77(4):570-5; discussion 576. PubMed ID: 25250596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.
    Chaves-Olarte E; Weidmann M; Eichel-Streiber C; Thelestam M
    J Clin Invest; 1997 Oct; 100(7):1734-41. PubMed ID: 9312171
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The receptors for bacterial enterotoxins].
    Lucas F; Corthier G
    Ann Rech Vet; 1991; 22(2):127-45. PubMed ID: 1654761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Elevated serum antibody response to toxin A following splenic abscess due to Clostridium difficile.
    Stieglbauer KT; Gruber SA; Johnson S
    Clin Infect Dis; 1995 Jan; 20(1):160-2. PubMed ID: 7727643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors.
    Wolfhagen MJ; Torensma R; Fluit AC; Aarsman CJ; Jansze M; Verhoef J
    Toxicon; 1994 Jan; 32(1):129-32. PubMed ID: 9237345
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile toxin A and its effects on cells.
    Fiorentini C; Thelestam M
    Toxicon; 1991; 29(6):543-67. PubMed ID: 1926159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.
    Vesely DL; Straub KD; Nolan CM; Rolfe RD; Finegold SM; Monson TP
    Infect Immun; 1981 Jul; 33(1):285-91. PubMed ID: 6114928
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit.
    Kelly CP; Becker S; Linevsky JK; Joshi MA; O'Keane JC; Dickey BF; LaMont JT; Pothoulakis C
    J Clin Invest; 1994 Mar; 93(3):1257-65. PubMed ID: 7907603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clostridium difficile toxin A induces a specific antisecretory factor which protects against intestinal mucosal damage.
    Torres J; Jennische E; Lange S; Lönnroth I
    Gut; 1991 Jul; 32(7):791-5. PubMed ID: 1855687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell surface binding site for Clostridium difficile enterotoxin: evidence for a glycoconjugate containing the sequence Gal alpha 1-3Gal beta 1-4GlcNAc.
    Krivan HC; Clark GF; Smith DF; Wilkins TD
    Infect Immun; 1986 Sep; 53(3):573-81. PubMed ID: 3744552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haemagglutination activity of toxigenic and non-toxigenic strains of Clostridium difficile.
    Meng XQ; Yamakawa K; Ogura H; Nakamura S
    FEMS Microbiol Lett; 1994 May; 118(1-2):141-4. PubMed ID: 8013869
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters.
    Kim PH; Iaconis JP; Rolfe RD
    Infect Immun; 1987 Dec; 55(12):2984-92. PubMed ID: 3679541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of Clostridium difficile Toxin A by immunoblotting.
    Rautenberg P; Stender F; Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Feb; 261(1):29-42. PubMed ID: 3518293
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selective neutralization of a bacterial enterotoxin by serum immunoglobulin A in response to mucosal disease.
    Johnson S; Sypura WD; Gerding DN; Ewing SL; Janoff EN
    Infect Immun; 1995 Aug; 63(8):3166-73. PubMed ID: 7622244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Production of monoclonal antibody to Clostridium difficile toxin A which neutralizes enterotoxicity but not haemagglutination activity.
    Kamiya S; Yamakawa K; Meng XQ; Ogura H; Nakamura S
    FEMS Microbiol Lett; 1991 Jul; 65(3):311-5. PubMed ID: 1916231
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dithiothreitol generates an activated 250,000 mol. wt form of Clostridium difficile toxin B.
    Shoshan MC; Bergman T; Thelestam M; Florin I
    Toxicon; 1993 Jul; 31(7):845-52. PubMed ID: 8212030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Production, purification and characterization of Clostridium difficile toxic proteins different from toxin A and from toxin B.
    Torres JF; Lönnroth I
    Biochim Biophys Acta; 1989 Oct; 998(2):151-7. PubMed ID: 2506935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.
    Qamar A; Aboudola S; Warny M; Michetti P; Pothoulakis C; LaMont JT; Kelly CP
    Infect Immun; 2001 Apr; 69(4):2762-5. PubMed ID: 11254650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.